Lack of Pharmacokinetic Drug Interaction Between Oral Posaconazole and Caspofungin or Micafungin
| Autor: | Gopal Krishna, Eric Beresford, Xin Yu, Lei Ma, Edward Power, Donna Vickery, Matthew Medlock, Carl Noren |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
Adult
Male Posaconazole Antifungal Agents Adolescent Echinocandin Administration Oral Pharmacology Echinocandins Lipopeptides Young Adult chemistry.chemical_compound Pharmacokinetics Caspofungin Humans Medicine Drug Interactions Pharmacology (medical) Dosing Infusions Intravenous Adverse effect business.industry Micafungin Triazoles Drug interaction bacterial infections and mycoses chemistry Area Under Curve Female business medicine.drug |
| Zdroj: | The Journal of Clinical Pharmacology. 51:84-92 |
| ISSN: | 0091-2700 |
| Popis: | The objective of this phase 1, open-label, parallel, randomized study was to determine the effect of posaconazole on the pharmacokinetics of caspofungin and micafungin in 67 healthy subjects. Caspofungin (70 mg on day 1, 50 mg on days 2-14 once daily; 1-hour intravenous infusion) (cohort 1) or micafungin (150 mg once daily days 1-7; 1-hour IV infusion) (cohort 2) was administered alone or with posaconazole oral suspension 400 mg twice daily, on days 1 to 14 (cohort 1) or days 1 to 7 (cohort 2). Pharmacokinetic parameters, maximum plasma concentration (C(max)), steady-state area under the plasma concentration-time curve over the dosing interval (AUC[τ]), and time to C(max) (T(max)) were assessed. Safety assessments included adverse events, clinical laboratory tests, vital signs, and electrocardiograms. Repeated posaconazole dosing did not affect caspofungin or micafungin pharmacokinetics. Log-transformed ratio estimates of caspofungin with posaconazole C(max) and AUC(τ) were 90% and 98%, respectively, of those with caspofungin alone at day 14; ratio estimates of micafungin with posaconazole C(max) and AUC(τ) were 104% and 109%, respectively, of those with micafungin alone at day 7. Median T(max) (1 hour) did not change. Coadministration of posaconazole with caspofungin or micafungin was generally well tolerated and did not affect the pharmacokinetics of either echinocandin. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text